The Square-backed event ticketing technology provider will float at the top of its range having previously raised almost $360m in equity funding.

Tencent and Xiaomi-backed news aggregation platform Qutoutiao floated at the foot of its range, in an IPO in which JD.com invested about $14m.

The GSK-backed small molecule drug developer floated at the top of its range to raise just over $106m.

The Tencent, Baidu, Lenovo and JD.com-backed electric carmaker floated near the foot of its range at a reported $6.4bn valuation.

The Tencent-backed local services portal has priced the offering near the top of its range at a valuation of about $52bn.

A month after Sutro closed an $85.4m series E round, the cancer drug developer, based on research at Stanford, has filed for a $75m initial public offering.

Since the beginning of 2017, Global Corporate Venturing (GCV) Analytics has tracked and seen a number of companies backed by China-based internet company Tencent go public in Hong Kong and the US.

Ascentage Pharma, based on research at University of Michigan, has filed to list in Hong Kong having raised about $235m in funding.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.

Sensyne Health has completed a $76m initial public offering and will begin trading on Aim tomorrow, offering an exit to University of Oxford.